S664 Outcomes of Positive mt-sDNA Screens in Patients Aged 45-49: A Retrospective Cohort Study

Introduction: Given the increasing incidence of young-onset colorectal cancer (YO-CRC) in people <50, the USPSTF lowered its CRC screening recommendations in 2021 to start at 45 years of age with similar options as in older individuals. We sought to identify the yield and follow through with colonoscopy of one of the approved screening options, multi-target stool DNA (mt-sDNA) testing, in younger patients. Methods: Medical charts of 228 patients aged 45-49 with a positive mt-sDNA between 3/1/23–7/1/24 were reviewed. We evaluated follow through with and findings at colonoscopy. Advanced adenomas (AAs), precancerous lesions that are considered to have the highest risk of developing CRC, were identified based on previously defined criteria. χ2 and t-tests for categorical and continuous variables were used, respectively, and a P-value of <0.05 was considered statistically significant. Results: Of the 228 patients reviewed (44.7% male, 55.3% female), 161 (70.6%) underwent a follow-up colonoscopy within 1 year. Of those, 36 (22.4%) had no polyps, 76 (46.9%) had non-advanced adenomas only (NAAs), and 49 (30.2%) had at least 1 AA. One patient was diagnosed with YO-CRC. Patients with AAs had a higher body mass index (BMI) than those without (34.1 vs 31.7 kg/m2, P = 0.04) but did not differ by other previously identified CRC risk factors. The positive predictive value (PPV) of this mt-sDNA test is calculated to be 35%, which is comparable to older populations. Conclusion: Younger individuals were observed to have a colonoscopy follow-up rate and PPV consistent with older populations with a positive mt-sDNA test. BMI is a clear risk factor in AA development in younger individuals. As more than 30% of patients had advanced adenomas at colonoscopy, mt-sDNA is a viable and valuable screening option in younger populations. Although most patients did undergo colonoscopy, interventions to improve adherence with follow-up colonoscopy are needed in this population.

Authors

Publication Details

Journal
The American Journal of Gastroenterology
Published
2025-10-01
DOI
https://doi.org/10.14309/01.ajg.0001130116.32668.31
Primary Topic
Colorectal Cancer Screening and Detection
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

S664 Outcomes of Positive mt-sDNA Screens in Patients Aged 45-49: A Retrospective Cohort Study

Katie E. Zhang, Gregory S. Cooper
The American Journal of Gastroenterology
Colorectal Cancer Screening and Detection
article

S664 Outcomes of Positive mt-sDNA Screens in Patients Aged 45-49: A Retrospective Cohort Study

Katie E. Zhang, Gregory S. Cooper
article en

Abstract

Introduction: Given the increasing incidence of young-onset colorectal cancer (YO-CRC) in people <50, the USPSTF lowered its CRC screening recommendations in 2021 to start at 45 years of age with similar options as in older individuals. We sought to identify the yield and follow through with colonoscopy of one of the approved screening options, multi-target stool DNA (mt-sDNA) testing, in younger patients. Methods: Medical charts of 228 patients aged 45-49 with a positive mt-sDNA between 3/1/23–7/1/24 were reviewed. We evaluated follow through with and findings at colonoscopy. Advanced adenomas (AAs), precancerous lesions that are considered to have the highest risk of developing CRC, were identified based on previously defined criteria. χ2 and t-tests for categorical and continuous variables were used, respectively, and a P-value of <0.05 was considered statistically significant. Results: Of the 228 patients reviewed (44.7% male, 55.3% female), 161 (70.6%) underwent a follow-up colonoscopy within 1 year. Of those, 36 (22.4%) had no polyps, 76 (46.9%) had non-advanced adenomas only (NAAs), and 49 (30.2%) had at least 1 AA. One patient was diagnosed with YO-CRC. Patients with AAs had a higher body mass index (BMI) than those without (34.1 vs 31.7 kg/m2, P = 0.04) but did not differ by other previously identified CRC risk factors. The positive predictive value (PPV) of this mt-sDNA test is calculated to be 35%, which is comparable to older populations. Conclusion: Younger individuals were observed to have a colonoscopy follow-up rate and PPV consistent with older populations with a positive mt-sDNA test. BMI is a clear risk factor in AA development in younger individuals. As more than 30% of patients had advanced adenomas at colonoscopy, mt-sDNA is a viable and valuable screening option in younger populations. Although most patients did undergo colonoscopy, interventions to improve adherence with follow-up colonoscopy are needed in this population.

The American Journal of GastroenterologyVol. 120(10S2)
Openalex Percentile: Top 54%
Colorectal Cancer Screening and Detection
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

S664 Outcomes of Positive mt-sDNA Screens in Patients Aged 45-49: A Retrospective Cohort Study — Katie E. Zhang, Gregory S. Cooper · The American Journal of Gastroenterology (2025) | TGRS Research Map | TGRS